Compare ICL & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICL | UHS |
|---|---|---|
| Founded | 1968 | 1978 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Hospital/Nursing Management |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 9.3B |
| IPO Year | 2001 | 1994 |
| Metric | ICL | UHS |
|---|---|---|
| Price | $5.62 | $141.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $6.10 | ★ $216.36 |
| AVG Volume (30 Days) | ★ 1.2M | 929.7K |
| Earning Date | 05-13-2026 | 04-27-2026 |
| Dividend Yield | ★ 3.31% | 0.48% |
| EPS Growth | N/A | ★ 37.34 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $17,364,829,000.00 |
| Revenue This Year | $6.04 | $7.67 |
| Revenue Next Year | $3.27 | $4.99 |
| P/E Ratio | $31.41 | ★ $25.69 |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $4.76 | $140.76 |
| 52 Week High | $7.35 | $246.33 |
| Indicator | ICL | UHS |
|---|---|---|
| Relative Strength Index (RSI) | 36.32 | 26.77 |
| Support Level | $5.21 | N/A |
| Resistance Level | $5.85 | $186.91 |
| Average True Range (ATR) | 0.14 | 5.41 |
| MACD | -0.15 | -0.98 |
| Stochastic Oscillator | 4.12 | 4.38 |
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates revenue from Brazil, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.